| For: | Trifan A, Stanciu C, Girleanu I, Stoica OC, Singeap AM, Maxim R, Chiriac SA, Ciobica A, Boiculese L. Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis. World J Gastroenterol 2017; 23(35): 6500-6515 [PMID: 29085200 DOI: 10.3748/wjg.v23.i35.6500] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i35/6500.htm |
| Number | Citing Articles |
| 1 |
Hyun Jin Song, Nakyung Jeon, Patrick Squires. The association between acid-suppressive agent use and the risk of cancer: a systematic review and meta-analysis. European Journal of Clinical Pharmacology 2020; 76(10) doi: 10.1007/s00228-020-02927-8
|
| 2 |
Annelies Boven, Harry Vranken, Erika Vlieghe, Annemarie Boleij, Katja Fall, Lars Engstrand, Nele Brusselaers. Commonly prescribed drugs as risk factors for Clostridioides difficile infections: a Swedish population-based case–control study. Gut 2026; doi: 10.1136/gutjnl-2025-337629
|
| 3 |
Aries Chavira, Pedro Belda-Ferre, Tomasz Kosciolek, Farhana Ali, Pieter C. Dorrestein, Rob Knight. Concepts and Principles of Pharmacology. Handbook of Experimental Pharmacology 2019; 260 doi: 10.1007/164_2019_317
|
| 4 |
Michelle Doll, Alexandre R. Marra, Anucha Apisarnthanarak, Amal Saif Al-Maani, Salma Abbas, Victor D. Rosenthal. Prevention of Clostridioides difficile in hospitals: A position paper of the International Society for Infectious Diseases. International Journal of Infectious Diseases 2021; 102 doi: 10.1016/j.ijid.2020.10.039
|
| 5 |
Lyudmila Boyanova, José Medeiros, Daniel Yordanov, Raina Gergova, Rumyana Markovska. Turmeric and curcumin as adjuncts in controlling Helicobacter pylori-associated diseases: a narrative review. Letters in Applied Microbiology 2024; 77(6) doi: 10.1093/lambio/ovae049
|
| 6 |
Sam Harper, Muralikrishnan Kartha, Stuart Mealing, Lars Lundell. A cost-effectiveness analysis of RefluxStop against relevant therapeutic alternatives for chronic gastroesophageal reflux disease in Sweden. Expert Review of Pharmacoeconomics & Outcomes Research 2025; 25(3) doi: 10.1080/14737167.2024.2417774
|
| 7 |
Paulina Głowacka, Aleksandra Bartkowska, Paulina Orzechowska, Gabriela Mastej-Witek, Alicja Okupniak, Gabriela Budziszewska, Mateusz Nieczyporuk, Aneta Dziurdź, Aleksandra Łupicka, Monika Ziemba. Long-term proton pump inhibitor therapy in daily clinical practice – balancing benefits and potential risks: a narrative review.. Biuletyn Głównej Biblioteki Lekarskiej 2026; 59(387) doi: 10.2478/bgbl-2026-0015
|
| 8 |
Luisa F. Duque-Buitrago, Antonio Tornero-Martínez, Verónica Loera-Castañeda, Rosalva Mora-Escobedo. Use of food and food-derived products in the treatment of gastritis: A systematic review. Critical Reviews in Food Science and Nutrition 2023; 63(22) doi: 10.1080/10408398.2021.2024131
|
| 9 |
P. Gendre, J. Mocquard, J.F. Huon. Appropriateness of proton pump inhibitors prescription in patient admitted to hospital: An observational study. Annales Pharmaceutiques Françaises 2023; 81(4) doi: 10.1016/j.pharma.2022.11.003
|
| 10 |
Janet K. Sluggett, Samanta Lalic, Sarah M. Hosking, Brett Ritchie, Jennifer McLoughlin, Terry Shortt, Leonie Robson, Tina Cooper, Kelly A. Cairns, Jenni Ilomäki, Renuka Visvanathan, J. Simon Bell. Root Cause Analysis to Identify Medication and Non-Medication Strategies to Prevent Infection-Related Hospitalizations from Australian Residential Aged Care Services. International Journal of Environmental Research and Public Health 2020; 17(9) doi: 10.3390/ijerph17093282
|
| 11 |
Ilsoo Kim, Joon Sung Kim, Jae Myung Park, Dae Young Cheung, Tae Ho Kim, Woo Chul Chung, Jung-Hwan Oh, Hyun Ho Choi, Seung-Woo Lee. Clostridioides difficile Infection in Patients Undergoing Acid-Suppressive Treatment: A Large Cohort Study with Propensity Score Matching. Digestive Diseases 2025; 43(5) doi: 10.1159/000547573
|
| 12 |
Xiaoqun Lv, Jun Zhang, Miao Jiang, Yujuan Liu, Weifang Ren, Zhonghong Fang. Clostridium difficile-associated diarrhea following the therapy with antibiotic and proton pump inhibitors in a 77-year-old man with several comorbidities. Medicine 2019; 98(13) doi: 10.1097/MD.0000000000015004
|
| 13 |
Michael Simonov, Erica A. Abel, Melissa Skanderson, Amir Masoud, Ronald G. Hauser, Cynthia A. Brandt, Francis P. Wilson, Loren Laine. Use of Proton Pump Inhibitors Increases Risk of Incident Kidney Stones. Clinical Gastroenterology and Hepatology 2021; 19(1) doi: 10.1016/j.cgh.2020.02.053
|
| 14 |
Yoon Hee Park, Jong Mi Seong, Soyeon Cho, Hye Won Han, Jae Youn Kim, Sook Hee An, Hye Sun Gwak. Effects of proton pump inhibitor use on risk of Clostridium difficile infection: a hospital cohort study. Journal of Gastroenterology 2019; 54(12) doi: 10.1007/s00535-019-01598-2
|
| 15 |
Rawa Bapir, Kamran Hassan Bhatti, Ahmed Eliwa, Herney Andrés García-Perdomo, Nazim Gherabi, Derek Hennessey, Vittorio Magri, Panagiotis Mourmouris, Adama Ouattara, Gianpaolo Perletti, Joseph Philipraj, Konstantinos Stamatiou, Musliu Adetola Tolani, Lazaros Tzelves, Alberto Trinchieri, Noor Buchholz. Risk of urinary stone formation associated to proton pump inhibitors: A systematic review and metanalysis. Archivio Italiano di Urologia e Andrologia 2022; 94(4) doi: 10.4081/aiua.2022.4.507
|
| 16 |
Lukas Macke, Christian Schulz, Leandra Koletzko, Peter Malfertheiner. Systematic review: the effects of proton pump inhibitors on the microbiome of the digestive tract—evidence from next‐generation sequencing studies. Alimentary Pharmacology & Therapeutics 2020; 51(5) doi: 10.1111/apt.15604
|
| 17 |
Annie S Hong, Wen Yuan Yu, Jenny M Hong, Chad L Cross, Mohamed Azab, Gordon Ohning, Mahendran Jayaraj. Proton pump inhibitor in upper gastrointestinal fecal microbiota transplant: A systematic review and analysis. Journal of Gastroenterology and Hepatology 2020; 35(6) doi: 10.1111/jgh.14958
|
| 18 |
Ummi Maimunah, Andreas Agung Kurniawan, Andrio Palayukan. Adverse Effects of Long-term Proton Pump Inhibitors in Chronic Liver Disease Patients – A Preliminary Article Review. Review of Clinical Pharmacology and Pharmacokinetics - International Edition 2024; 38(1) doi: 10.61873/WWAY6273
|
| 19 |
Lia Totleben, Joel Thomas, Daniel Austin. Drug-mediated disruption of the aging gut microbiota and mucosal immune system. Frontiers in Aging 2025; 6 doi: 10.3389/fragi.2025.1603847
|
| 20 |
Alicja Smolińska, Maria Bołoz, Izabela Grzyb, Jan Szewczyk, Sylwia Haba, Ewa Dapkiewicz, Dawid Gąsowski, Katarzyna Łysynkiewicz, Zuzanna Wątek, Patrycja Krawczyk. LONG-TERM PROTON PUMP INHIBITOR THERAPY: IS IT REALLY SAFE? A NARRATIVE REVIEW. International Journal of Innovative Technologies in Social Science 2026; 2(3(51)) doi: 10.31435/ijitss.3(51).2026.6140
|
| 21 |
Wei-Te Hung, Ying-Hock Teng, Shun-Fa Yang, Han-Wei Yeh, Ying-Tung Yeh, Yu-Hsun Wang, Ming-Yung Chou, Ming-Chih Chou, Chi-Ho Chan, Chao-Bin Yeh. Association between Proton Pump Inhibitor Use and CNS Infection Risk: A Retrospective Cohort Study. Journal of Clinical Medicine 2018; 7(9) doi: 10.3390/jcm7090252
|
| 22 |
Joyita Bharati, Urmila Anandh, Camille N. Kotton, Thomas Mueller, Aakash K. Shingada, Raja Ramachandran. Diagnosis, Prevention, and Treatment of Infections in Kidney Transplantation. Seminars in Nephrology 2023; 43(5) doi: 10.1016/j.semnephrol.2023.151486
|
| 23 |
Sam Harper, Khanh Ha Bui, Stuart Mealing, Daniel Sanchez, Pablo Priego Jiménez, Carlos Moreno Sanz. Cost-Effectiveness of RefluxStop Versus Nissen Fundoplication and Proton Pump Inhibitors for Refractory Gastroesophageal Reflux Disease: A Spanish Healthcare Perspective. PharmacoEconomics - Open 2026; 10(2) doi: 10.1007/s41669-025-00636-5
|
| 24 |
Melina Luzzi Zarricueta, Felipe Leonardo Fagundes, Quélita Cristina Pereira, Simone Queiroz Pantaleão, Raquel de Cássia dos Santos. Relationship between Hormonal Modulation and Gastroprotective Activity of Malvidin and Cyanidin Chloride: In Vivo and In Silico Approach. Pharmaceutics 2022; 14(3) doi: 10.3390/pharmaceutics14030565
|
| 25 |
Juan Manuel Mendive. Safety in the use of proton pump inhibitors. Medicina Clínica (English Edition) 2026; 166(5) doi: 10.1016/j.medcle.2026.107409
|
| 26 |
Toshiaki Komatsu, Ryosuke Inagaki, Shintaro Azuma, Shunya Mochida, Yosuke Sato, Yoshinori Seto, Shin Nihonyanagi, Takayuki Hoshiyama, Tatsuhiko Wada, Yoko Takayama, Koichiro Atsuda. Evaluation of a carbapenem antimicrobial stewardship program and clinical outcomes in a Japanese hospital. Journal of Infection and Chemotherapy 2022; 28(7) doi: 10.1016/j.jiac.2022.03.006
|
| 27 |
Jianwei Ren, Yu Xin, Jianye Zhang, Yan Liu, Yulei Liu, Guangfa Zhu. Clinical presentation, aetiological characteristics, risk factors and in-hospital outcome of nosocomial infection following acute aortic dissection surgery in adult patients. BMC Cardiovascular Disorders 2025; 25(1) doi: 10.1186/s12872-025-04692-x
|
| 28 |
Yun-Jie Ma, Zong-Xun Cao, Yong Li, Shun-Yi Feng. Proton pump inhibitor use increases hepatic encephalopathy risk: A systematic review and meta-analysis. World Journal of Gastroenterology 2019; 25(21): 2675-2682 doi: 10.3748/wjg.v25.i21.2675
|
| 29 |
Jeremy Klein, Robert T. Kavitt. Gastroesophageal Reflux Disease. 2023; doi: 10.1007/978-3-031-48241-0_8
|
| 30 |
Diana-Elena Floria, Mahmoud Obeidat, Szilárd Váncsa, Sarolta Beáta Kávási, László Földvári-Nagy, Péter Hegyi, Dániel Sándor Veres, Vasile-Liviu Drug, Bálint Erőss.
Proton pump inhibitors are not associated with an increased risk of
Clostridioides difficile
infection: a systematic review and meta-analysis of randomized controlled trials
. Gut Microbes 2025; 17(1) doi: 10.1080/19490976.2025.2562341
|
| 31 |
Gloria M. Aguirre-García, Elvira Garza-González, Rayo Morfin-Otero, Adrián Camacho-Ortiz. Clostridioides difficile infections among healthcare workers. American Journal of Infection Control 2020; 48(10) doi: 10.1016/j.ajic.2020.01.012
|
| 32 |
Run-hua Li, Ying-ying Yang, Wen Xu, Gui-li Xia, Qing Cheng, Xiao-bing Cui, Ying Zhu, Xiao-hua Bao. Efficacy and safety of endoscopic cardia constriction ligation with a single-use endoscope versus a reusable endoscope for refractory gastroesophageal reflux disease: protocol for a multicenter randomized controlled trial. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1832310
|
| 33 |
Jessica S. Tischendorf, Mary J. Knobloch, Jackson S. Musuuza, Nasia Safdar. Using a Systems Engineering Framework to Evaluate Proton Pump Inhibitor Prescribing in Critically Ill Patients. Journal for Healthcare Quality 2020; 42(4) doi: 10.1097/JHQ.0000000000000209
|
| 34 |
Sukai Zhang, Chen Ma, Haiyue Zhang, Congcong Zhao, Ruibing Guo, Jiahao Liu, Jing Wang, Jing Yuan, Kai Jia, Airong Wu, Yanjiong Chen, Jin’e Lei. Toxin genotypes, antibiotic resistance and their correlations in Clostridioides difficile isolated from hospitals in Xi’an, China. BMC Microbiology 2024; 24(1) doi: 10.1186/s12866-024-03327-z
|
| 35 |
Tomasz Sylwestrzak, Michalina Ciosek, Katarzyna Połomska, Jarosław Kobiela, Piotr Spychalski. Study of Treatment with Intensified Omeprazole to Prevent High-Output Stoma—A Protocol for a Randomized, Parallel-Group, Open-Label, Superiority Trial in Adults Undergoing Ileostomy (STOP-HOS-1). Journal of Clinical Medicine 2026; 15(5) doi: 10.3390/jcm15051841
|
| 36 |
. 2022; doi: 10.70675/dcdc2ad0z8b91z4774z97a2zad2f42b36f14
|
| 37 |
Trusha Nana, Chanelle Moore, Tom Boyles, Adrian J. Brink, Joy Cleghorn, Lesley M. Devenish, Briette du Toit, Ernst S. Fredericks, Molebogeng R. Lekalakala-Mokaba, Caroline Maluleka, Muhammad N. Rajabally, Gary Reubenson, Liliwe Shuping, Karin Swart, Khine Swe Swe Han, Jeannette Wadula, Justyna Wojno, Warren Lowman. South African Society of Clinical Microbiology Clostridioides difficile infection diagnosis, management and infection prevention and control guideline. Southern African Journal of Infectious Diseases 2020; 35(1) doi: 10.4102/sajid.v35i1.219
|
| 38 |
Yafet Mamo, Michael H Woodworth, Tiffany Wang, Tanvi Dhere, Colleen S Kraft. Durability and Long-term Clinical Outcomes of Fecal Microbiota Transplant Treatment in Patients With Recurrent Clostridium difficile Infection. Clinical Infectious Diseases 2018; 66(11) doi: 10.1093/cid/cix1097
|
| 39 |
Łukasz Lis, Andrzej Konieczny, Michał Sroka, Anna Ciszewska, Kornelia Krakowska, Tomasz Gołębiowski, Zbigniew Hruby. Clinical Determinants Predicting Clostridioides difficile Infection among Patients with Chronic Kidney Disease. Antibiotics 2022; 11(6) doi: 10.3390/antibiotics11060785
|
| 40 |
Mengling Ouyang, Shupeng Zou, Qian Cheng, Xuan Shi, Yazheng Zhao, Minghui Sun. Vonoprazan-associated Clostridioides difficile infection: an analysis of the Japanese Adverse Drug Event Report and the FDA Adverse Event Reporting System. Therapeutic Advances in Drug Safety 2024; 15 doi: 10.1177/20420986241260211
|
| 41 |
Hee-Eun Hong, A-Sol Kim, Mi-Rae Kim, Hae-Jin Ko, Min Kyu Jung. Does the Use of Proton Pump Inhibitors Increase the Risk of Pancreatic Cancer? A Systematic Review and Meta-Analysis of Epidemiologic Studies. Cancers 2020; 12(8) doi: 10.3390/cancers12082220
|
| 42 |
Wildan Hidayah Al Qindy, Fitri Oktaviani Nurdin, Aulia Khaerunisa, Meisya Diffa Amalia Putri, Indah Laily Hilmi, Mukarromah Dita Putri. Evaluasi Bukti dari Uji Klinis tentang Interaksi Antibiotik dan Antasida: Suatu Tinjauan Sistematis Literatur. Journal of Pharmaceutical and Sciences 2025; doi: 10.36490/journal-jps.com.v8i4.1093
|
| 43 |
R. Quera, P. Nuñez, C. von Muhlenbrock, R. Espinoza. Fecal microbiota transplantation through colonoscopy in the treatment of recurrent Clostridioides difficile: Experience at a university center. Revista de Gastroenterología de México (English Edition) 2024; 89(4) doi: 10.1016/j.rgmxen.2024.03.004
|
| 44 |
Angela Horvath, Vanessa Stadlbauer. Das Mikrobiom als Drehscheibe für Nebenwirkungen der Protonenpumpenhemmer-Therapie. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie 2021; 146(02) doi: 10.1055/a-1312-7587
|
| 45 |
. 2024; doi: 10.70675/32b76beaz4116z4679z82fbze0b633f58b0e
|
| 46 |
Eric A. Pasman, Bruce Ong, Claire P. Witmer, Cade M. Nylund. Proton Pump Inhibitors in Children: the Good, the Bad, and the Ugly. Current Allergy and Asthma Reports 2020; 20(8) doi: 10.1007/s11882-020-00926-4
|
| 47 |
Sae Aratani, Takeshi Matsunobu, Takahiro Kawai, Hirotake Suzuki, Norihiro Usukura, Kimihiro Okubo, Yukinao Sakai. Syndrome of Inappropriate Secretion of Antidiuretic Hormone Caused by Very Short-term Use of Proton Pump Inhibitor. The Keio Journal of Medicine 2021; 70(1) doi: 10.2302/kjm.2020-0008-CR
|
| 48 |
Gheith Yousif. Critical Hypomagnesemia and Seizure Induced by Chronic Use of Proton Pump Inhibitors (PPIs). Translation: The University of Toledo Journal of Medical Sciences 2019; 6 doi: 10.46570/utjms.vol6-2019-285
|
| 49 |
Linlin Yin, Hongfei Tu, Yue Zhu, Jingjing Qian, Yang Yang, Chen Wei, Chengliang Ding, Bin Zhang. Investigating the relationship between Helicobacter pylori and intestinal Clostridioides difficile infection: evidence from a cross-sectional study. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-04227-w
|
| 50 |
Amaya Echeverría Gorriti, Javier Gorricho Mendívil, Janire Etxegia Apezetxea, Ibai Tamayo Rodríguez, Julián Librero López, Andrea Rodríguez Esquíroz, M. Concepción Celaya Lecea, Javier Garjón Parra, Lorea Sanz Álvarez, Marta Marín Marín, Patricia García González, Julen Fernández González, Rebeca Irisarri Garde, Ana Campillo Arregui. Population-based deprescribing strategy for proton pump inhibitors: Health outcomes from a case-control study. Medicina Clínica (English Edition) 2026; 166(5) doi: 10.1016/j.medcle.2026.107414
|
| 51 |
Sam Harper, Lukasz Grodzicki, Stuart Mealing, Elizabeth Gemmill, Paul Goldsmith, Ahmed Ahmed. Budget Impact of RefluxStopTM as a Treatment for Patients with Refractory Gastro-oesophageal Reflux Disease in the United Kingdom. Journal of Health Economics and Outcomes Research 2024; doi: 10.36469/jheor.2024.90924
|
| 52 |
Danilo Menichelli, Gianluca Gazzaniga, Francesco Del Sole, Arianna Pani, Pasquale Pignatelli, Daniele Pastori. Acute upper and lower gastrointestinal bleeding management in older people taking or not taking anticoagulants: a literature review. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1399429
|
| 53 |
Nisar Amin, Harleen Chela, Muhammad Faisal Mubarak, Mark Ayoub, Ebubekir Daglilar. Proton Pump Inhibitor Use Following Esophageal Variceal Ligation and Its Impact on Clinical Outcomes: Real-World Data from the TriNetX Global Collaborative Network. Diagnostics 2025; 15(13) doi: 10.3390/diagnostics15131653
|
| 54 |
Amaya Echeverría Gorriti, Javier Gorricho Mendívil, Janire Etxegia Apezetxea, Ibai Tamayo Rodríguez, Julián Librero López, Andrea Rodríguez Esquíroz, M. Concepción Celaya Lecea, Javier Garjón Parra, Lorea Sanz Álvarez, Marta Marín Marín, Patricia García González, Julen Fernández González, Rebeca Irisarri Garde, Ana Campillo Arregui. Estrategia poblacional de deprescripción de inhibidores de la bomba de protones: resultados en salud de un estudio de casos y controles. Medicina Clínica 2026; 166(5) doi: 10.1016/j.medcli.2026.107414
|
| 55 |
Junmo Kim, Joo Seong Kim, Sae-Hoon Kim, Sooyoung Yoo, Jun Kyu Lee, Kwangsoo Kim. Deep learning-based prediction of Clostridioides difficile infection caused by antibiotics using longitudinal electronic health records. npj Digital Medicine 2024; 7(1) doi: 10.1038/s41746-024-01215-4
|
| 56 |
Sam Harper, Muralikrishnan Kartha, Stuart Mealing, Maurizio Pavanello, Luigi Bonavina. The Economic Impact of Introducing RefluxStop for Refractory Gastroesophageal Reflux Disease on the Italian Healthcare System. PharmacoEconomics - Open 2024; 8(6) doi: 10.1007/s41669-024-00521-7
|
| 57 |
Kevin A Brown, Bryan Coburn, Alejandro Hernandez, Bradley J Langford, Valerie Leung, Derek MacFadden, Ashley M Rooney, Kevin L Schwartz, Nick Daneman. Antibiotic and Nonantibiotic Drugs Associated With Clostridioides difficile Infection Risk: a Pharmacopoeia-Wide Case-Cohort Study. The Journal of Infectious Diseases 2026; 233(5) doi: 10.1093/infdis/jiag001
|
| 58 |
Xiaoyi Gao, Zi Yi Shao, Noam Grysman, George T Grossberg. Proton Pump Inhibitor Use and Risk of Dementia in Older Adults: A Systematic Review. US Neurology 2023; 19(1) doi: 10.17925/USN.2023.19.1.21
|
| 59 |
Kate N. Wang, J. Simon Bell, Edwin C. K. Tan, Julia F. M. Gilmartin-Thomas, Michael J. Dooley, Jenni Ilomäki. Proton Pump Inhibitors and Infection-Related Hospitalizations Among Residents of Long-Term Care Facilities: A Case–Control Study. Drugs & Aging 2019; 36(11) doi: 10.1007/s40266-019-00704-6
|
| 60 |
Livio Enrico Del Vecchio, Marcello Fiorani, Ege Tohumcu, Stefano Bibbò, Serena Porcari, Maria Cristina Mele, Marco Pizzoferrato, Antonio Gasbarrini, Giovanni Cammarota, Gianluca Ianiro. Risk Factors, Diagnosis, and Management of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease. Microorganisms 2022; 10(7) doi: 10.3390/microorganisms10071315
|
| 61 |
Philip O. Katz, Kerry B. Dunbar, Felice H. Schnoll-Sussman, Katarina B. Greer, Rena Yadlapati, Stuart Jon Spechler. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. American Journal of Gastroenterology 2022; 117(1) doi: 10.14309/ajg.0000000000001538
|
| 62 |
Syeda Sahra, Mohammad Abureesh, Shivantha Amarnath, Motasem Alkhayyat, Rawan Badran, Abdullah Jahangir, Vivek Gumaste. <i>Clostridioides difficile </i>infection in liver cirrhosis patients: A population-based study in United States. World Journal of Hepatology 2021; 13(8): 926-938 doi: 10.4254/wjh.v13.i8.926
|
| 63 |
Laura Biganzoli, Saverio Cinieri, Rossana Berardi, Rebecca Pedersini, Amelia McCartney, Alessandro Marco Minisini, Elena Rota Caremoli, Simon Spazzapan, Emanuela Magnolfi, Antonella Brunello, Emanuela Risi, Raffaella Palumbo, Silvana Leo, Marco Colleoni, Sara Donati, Sabino De Placido, Laura Orlando, Mirco Pistelli, Veronica Parolin, Anna Mislang, Dimitri Becheri, Fabio Puglisi, Giuseppina Sanna, Elena Zafarana, Luca Boni, Giuseppe Mottino. EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancer. Breast Cancer Research 2020; 22(1) doi: 10.1186/s13058-020-01319-1
|
| 64 |
Hongbai Wang, Qipeng Luo, Yinan Li, Liang Zhang, Xie Wu, Fuxia Yan. Effect of Prophylactic Levosimendan on All-Cause Mortality in Pediatric Patients Undergoing Cardiac Surgery—An Updated Systematic Review and Meta-Analysis. Frontiers in Pediatrics 2020; 8 doi: 10.3389/fped.2020.00456
|
| 65 |
Russell Roark, Michael Sydor, Ahmed T. Chatila, Shifa Umar, Ramiro De La Guerra, Mohammad Bilal, Praveen Guturu. Management of gastroesophageal reflux disease. Disease-a-Month 2020; 66(1) doi: 10.1016/j.disamonth.2019.02.002
|
| 66 |
Ahmed Al-Marhabi, Ahmed Hashem, Bader Faiyaz Zuberi, Charles Onyekwere, Imran Lodhi, Mohamed Mounir, Saad Alkhowaiter, Sameer Al Awadhi, Vasudevan G. Naidoo, Yasser Hamada. The views of African and Middle Eastern Gastroenterologists on the management of mild-to-moderate, non-erosive gastro-esophageal reflux disease (GERD). Expert Review of Gastroenterology & Hepatology 2022; 16(3) doi: 10.1080/17474124.2022.2043744
|
| 67 |
Jeffrey A. Berinstein, Calen A. Steiner, Katelin J. Roth, Emily Briggs, Krishna Rao, Peter D. R. Higgins. Association of Household Pets, Common Dietary Factors, and Lifestyle Factors with Clostridium difficile Infection. Digestive Diseases and Sciences 2021; 66(1) doi: 10.1007/s10620-020-06123-7
|
| 68 |
Ah Young Lee, Kwanjoo Lee, Sun Jae Moon, Seung-Hun You, Jun-young Seo, Wonsuk Shin.
Risk of
Clostridioides difficile
infection with potassium-competitive acid blockers: A systematic review with restricted quantitative synthesis
. Therapeutic Advances in Drug Safety 2026; 17 doi: 10.1177/20420986261492840
|
| 69 |
Alex Al Khoury, Maryam Taheri Tanjani, Bretton Hari, Majid A. Almadi, Myriam Martel, Alan N. Barkun. Primary and Specialty Care Trainees’ Perceptions About Proton Pump Inhibitor Use. Journal of Clinical Gastroenterology 2025; 59(1) doi: 10.1097/MCG.0000000000001983
|
| 70 |
Srinivas Nalabothula, Shivali Chava, Neha Sai P Doddapaneni, Harsha Sai K Gottimukkala, Divya Durga. Proton Pump Inhibitor Use and Risk of Clostridioides difficile Infection: An Umbrella Review of 11 Meta-Analyses. Cureus 2025; doi: 10.7759/cureus.87383
|
| 71 |
Sibel Bolukcu, IsmailNecati Hakyemez, BilgeSumbul Gultepe, Gulay Okay, Bulent Durdu, MelihaMeric Koc, Turan Aslan. Clostridium difficile infection: Is there a change in the underlying factors? Inflammatory bowel disease and Clostridium difficile. Saudi Journal of Gastroenterology 2019; 25(6) doi: 10.4103/sjg.SJG_44_19
|
| 72 |
Ronald Hills, Benjamin Pontefract, Hillary Mishcon, Cody Black, Steven Sutton, Cory Theberge. Gut Microbiome: Profound Implications for Diet and Disease. Nutrients 2019; 11(7) doi: 10.3390/nu11071613
|
| 73 |
Hannah Donnelly, Tom Nolan. Dyspepsia: When to refer for endoscopy. InnovAiT: Education and inspiration for general practice 2019; 12(3) doi: 10.1177/1755738018785984
|
| 74 |
Shih‐Lun Teng, Che‐Han Hsu, Chia‐Chun Hsu, Jeng‐Shiann Shin, Jen‐Chieh Huang. Association of gastric acid suppressants with the development of spontaneous bacterial peritonitis in cirrhotic patients with ascites. Advances in Digestive Medicine 2020; 7(3) doi: 10.1002/aid2.13164
|
| 75 |
Mai Alalawi, Seba Aljahdali, Bashaer Alharbi, Lana Fagih, Raghad Fatani, Ohoud Aljuhani.
Clostridium difficile
infection in an academic medical center in Saudi Arabia: prevalence and risk factors
. Annals of Saudi Medicine 2020; 40(4) doi: 10.5144/0256-4947.2020.305
|
| 76 |
Wilson Jose Mesquita, Craig M. Kline, Patricia Vernier, Anna M. Ledgerwood, Charles E. Lucas. Failure of gastric prophylaxis against stress bleeding reflects inadequate pH control. Surgery 2018; 164(4) doi: 10.1016/j.surg.2018.05.019
|
| 77 |
Benedetta Govoni, Amedeo Zurlo, Roberto De Giorgio, Rosario Cultrera, Stefano Volpato. Clostridium difficile infection in a Geriatric Care Unit: clinical characteristics and prognosis. Journal of Gerontology and Geriatrics 2020; 69(1) doi: 10.36150/2499-6564-419
|
| 78 |
David A Katzka, Peter J Kahrilas. Advances in the diagnosis and management of gastroesophageal reflux disease. BMJ 2020; doi: 10.1136/bmj.m3786
|
| 79 |
Thakul Rattanasuwan, Adonice P. Khoury, Alex M. Ebied. Proton Pump Inhibitors: for What and for How Long. SN Comprehensive Clinical Medicine 2020; 2(6) doi: 10.1007/s42399-020-00268-2
|
| 80 |
Chien-Huei Huang, Yung-Hsin Tseng, Wen-Shan Tsai, Chien-Chou Su, Ching-Lan Cheng, Yea-Huei Kao Yang, Yu-Ching Chang, Yi-Hsuan Liu. Association Between Risk of Clostridium difficile Infection and Duration of Proton Pump Inhibitor or H2-Receptor Antagonist Use in Hospitalized Patients. Infectious Diseases and Therapy 2024; 13(2) doi: 10.1007/s40121-024-00922-5
|
| 81 |
Kuan-Sheng Wu, Ling-Shan Syue, Aristine Cheng, Ting-Yu Yen, Hsien-Meng Chen, Yu-Hsin Chiu, Yu-Lung Hsu, Chun-Hsiang Chiu, Ting-Yi Su, Wan-Lin Tsai, Wei-Yu Chen, Chung-Hao Huang, Huei-Min Hung, Ling-Ju Huang, Hong-Jie Kuo, Pei-Chin Lin, Ching-Hsiang Yang, Pi-Lien Hong, Susan Shin-Jung Lee, Yao-Shen Chen, Yung-Ching Liu, Li-Ming Huang. Recommendations and guidelines for the treatment of Clostridioides difficile infection in Taiwan. Journal of Microbiology, Immunology and Infection 2020; 53(2) doi: 10.1016/j.jmii.2020.02.002
|
| 82 |
Juan Manuel Mendive. Seguridad en la utilización de inhibidores de la bomba de protones. Medicina Clínica 2026; 166(5) doi: 10.1016/j.medcli.2026.107409
|
| 83 |
Sajesh K. Veettil, Saranrat Sadoyu, Elizabeth M Bald, Viji P. Chandran, Scott Anh Tuan Khuu, Panitan Pitak, Yeong Yeh Lee, Athira Balakrishnan Nair, Paul T. Antony, Alexander C. Ford, Nathorn Chaiyakunapruk. Association of proton‐pump inhibitor use with adverse health outcomes: A systematic umbrella review of meta‐analyses of cohort studies and randomised controlled trials. British Journal of Clinical Pharmacology 2022; 88(4) doi: 10.1111/bcp.15103
|
| 84 |
Hygienemaßnahmen bei Clostridioides difficile-Infektion (CDI). Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 2019; 62(7) doi: 10.1007/s00103-019-02959-1
|
| 85 |
Jennifer Bolt, Wade Thompson, Colleen Inglis. Appropriate Use of Proton Pump Inhibitors in Older Adults: Concerns and Solutions. Drugs & Aging 2026; 43(1) doi: 10.1007/s40266-025-01266-6
|
| 86 |
Justin Putnam, Allan B. Wolfson, Shahriar Zehtabshi. Proton Pump Inhibitors for Stress Ulcer Prophylaxis in Critically Ill Patients. Academic Emergency Medicine 2020; 27(7) doi: 10.1111/acem.13914
|
| 87 |
Florian Prechter, Andreas Stallmach. Clostridium difficile auf der Intensivstation. Wiener klinisches Magazin 2020; 23(5) doi: 10.1007/s00740-020-00354-0
|
| 88 |
Anna W. Boone, Thomas P. McCoy, Laurie Kennedy-Malone, Debra C. Wallace, Reham Yasin. Characteristics of Hospitalized Adults 55 and Older With Clostridioides difficile Infection. Gastroenterology Nursing 2023; 46(3) doi: 10.1097/SGA.0000000000000728
|
| 89 |
Megan Garland, Andrew J. Hryckowian, Martina Tholen, Kristina Oresic Bender, William W. Van Treuren, Sebastian Loscher, Justin L. Sonnenburg, Matthew Bogyo. The Clinical Drug Ebselen Attenuates Inflammation and Promotes Microbiome Recovery in Mice after Antibiotic Treatment for CDI. Cell Reports Medicine 2020; 1(1) doi: 10.1016/j.xcrm.2020.100005
|
| 90 |
Inès Ben Ghezala, Maxime Luu, Marc Bardou. An update on drug–drug interactions associated with proton pump inhibitors. Expert Opinion on Drug Metabolism & Toxicology 2022; 18(5) doi: 10.1080/17425255.2022.2098107
|
| 91 |
Elizabeth M. Salvo, Nicole C. Ferko, Sarah B. Cash, Ailish Gonzalez, Peter J. Kahrilas. Umbrella review of 42 systematic reviews with meta‐analyses: the safety of proton pump inhibitors. Alimentary Pharmacology & Therapeutics 2021; 54(2) doi: 10.1111/apt.16407
|
| 92 |
Célia Fortuna Rodrigues, Francisco Silva. The Rise, Fall, and Rethink of (Fluoro)quinolones: A Quick Rundown. Pathogens 2025; 14(6) doi: 10.3390/pathogens14060525
|
| 93 |
Domagoj Segregur, Talia Flanagan, James Mann, Andrea Moir, Eva M. Karlsson, Matthias Hoch, David Carlile, Sakina Sayah-Jeanne, Jennifer Dressman. Impact of Acid-Reducing Agents on Gastrointestinal Physiology and Design of Biorelevant Dissolution Tests to Reflect These Changes. Journal of Pharmaceutical Sciences 2019; 108(11) doi: 10.1016/j.xphs.2019.06.021
|
| 94 |
Tien-En Chang, Yi-Shin Huang, Chin-Lin Perng, Yi-Hsiang Huang, Ming-Chih Hou. Use of proton pump inhibitors and the risk of hepatocellular carcinoma. Journal of the Chinese Medical Association 2019; 82(10) doi: 10.1097/JCMA.0000000000000157
|
| 95 |
Ammar Abdulrahman Jairoun, Sabaa Saleh Al-Hemyari, Moyad Shahwan, Faris El-Dahiyat, Maimona Jairoun, Brian Godman, Amanj Kurdi, Samer H Zyoud. Access to non-prescription medicines via vending machines: key considerations to help transfer the self-care concept to the next generation while managing safety risks. Journal of Pharmaceutical Health Services Research 2022; 13(4) doi: 10.1093/jphsr/rmac044
|
| 96 |
Alexa R. Gale, Matthew Wilson. Gastrointestinal Emergencies. 2019; doi: 10.1007/978-3-319-98343-1_101
|
| 97 |
Emre Yekedüz, Mehmet Fatih Özbay, Dilek Çağlayan, Atila Yıldırım, Cihan Erol, Hasan Çağrı Yıldırım, Sezai Tunç, Neslihan Özyurt, Feyyaz Özdemir, Mehmet Ali Nahit Şendur, Abdurrahman Işıkdoğan, Saadettin Kılıçkap, Yüksel Ürün, Şuayib Yalçın, Mehmet Artaç, Hasan Şenol Coşkun, Güngör Utkan. Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study. European Journal of Clinical Pharmacology 2022; 78(12) doi: 10.1007/s00228-022-03403-1
|
| 98 |
Chun‐Ting Ho, Chia‐Chu Fu, Elise Chia‐Hui Tan, Wei‐Yu Kao, Pei‐Chang Lee, Yi‐Hsiang Huang, Teh‐Ia Huo, Ming‐Chih Hou, Jaw‐Ching Wu, Chien‐Wei Su. The association between proton‐pump inhibitor use and recurrence of hepatocellular carcinoma after hepatectomy. Journal of Gastroenterology and Hepatology 2024; 39(10) doi: 10.1111/jgh.16640
|
| 99 |
Nicolae Bacinschi, Ina Gutu, Alexandru Iarovoi, Maria Mihalachi-Anghel, Tatiana Rakovskaia. Proton pump inhibitors and the risk of Clostridioides difficile infection. Bulletin of the Academy of Sciences of Moldova. Medical Sciences 2025; (2(82)) doi: 10.52692/1857-0011.2025.2-82.37
|
| 100 |
Carlos E. Figueroa Castro, L. Silvia Munoz-Price. Advances in Infection Control for Clostridioides (Formerly Clostridium) difficile Infection. Current Treatment Options in Infectious Diseases 2019; 11(1) doi: 10.1007/s40506-019-0179-y
|
| 101 |
Ka Shing Cheung, Vincent K C Yan, Xuxiao Ye, Ivan F N Hung, Esther W Chan, Wai K Leung. Proton pump inhibitors associated with severe COVID‐19 among two‐dose but not three‐dose vaccine recipients. Journal of Gastroenterology and Hepatology 2024; 39(9) doi: 10.1111/jgh.16601
|
| 102 |
Maria Rogalidou, Alexandra Papadopoulou. Balancing therapeutic benefits and hidden risks of proton pump inhibitors in pediatric practice: a narrative review and update. Clinical and Experimental Pediatrics 2026; 69(3) doi: 10.3345/cep.2025.02761
|
| 103 |
Giulia Fiorini, Ilaria Maria Saracino, Matteo Pavoni, Laura Saccomanno, Dino Vaira. Efficacy of a new nutraceutical formulation (CHETOGERD®) in patients with nonerosive reflux disease (NERD): a prospective observational study. Internal and Emergency Medicine 2020; 15(7) doi: 10.1007/s11739-020-02309-z
|
| 104 |
John Papastergiou, Michelle Donnelly, Terence Yuen, Wilson Li, Bart van den Bemt. Community pharmacy–basedH. pyloriscreening for patients with uninvestigated dyspepsia. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada 2020; 153(2) doi: 10.1177/1715163520903065
|
| 105 |
Kaneez Fatima, Talal Almas, Shan Lakhani, Arshia Jahangir, Abdullah Ahmed, Ayra Siddiqui, Aiman Rahim, Saleha Ahmed Qureshi, Zukhruf Arshad, Shilpa Golani, Adeena Musheer. The Use of Proton Pump Inhibitors and COVID-19: A Systematic Review and Meta-Analysis. Tropical Medicine and Infectious Disease 2022; 7(3) doi: 10.3390/tropicalmed7030037
|
| 106 |
Tenzin Choden, Hui Zhang, Atsushi Sakuraba. Influence of proton pump inhibitor use on clinical outcomes of patients with inflammatory bowel disease. Annals of Medicine 2023; 55(1) doi: 10.1080/07853890.2023.2198775
|
| 107 |
Frederico Fonseca, Mario Forrester, Ana Margarida Advinha, Adriana Coutinho, Nuno Landeira, Maria Pereira. Clostridioides difficile Infection in Hospitalized Patients—A Retrospective Epidemiological Study. Healthcare 2023; 12(1) doi: 10.3390/healthcare12010076
|
| 108 |
Laura de Nies, Carolin M. Kobras, Mathew Stracy. Antibiotic-induced collateral damage to the microbiota and associated infections. Nature Reviews Microbiology 2023; 21(12) doi: 10.1038/s41579-023-00936-9
|
| 109 |
Yanfang Wei, Xue Su, Zhengdeng Li, Sheng Zheng. Transoral Endoscopic Clip Band Ligation Anti-reflux Therapy (C-BLART) for Gastroesophageal Reflux Disease: A Retrospective Analysis of Efficacy and Safety in 37 Patients. Digestive Diseases and Sciences 2026; doi: 10.1007/s10620-026-10192-5
|
| 110 |
Lenard M. Lichtenberger. Development of the PC-NSAID technology: From contact angle to Vazalore®. Drug Discovery Today 2023; 28(1) doi: 10.1016/j.drudis.2022.103411
|
| 111 |
Felipe Leonardo Fagundes, Quélita Cristina Pereira, Melina Luzzi Zarricueta, Raquel de Cássia dos Santos. Malvidin Protects against and Repairs Peptic Ulcers in Mice by Alleviating Oxidative Stress and Inflammation. Nutrients 2021; 13(10) doi: 10.3390/nu13103312
|
| 112 |
Ho Yu Ng, Wai K. Leung, Ka Shing Cheung. Association between Gut Microbiota and SARS-CoV-2 Infection and Vaccine Immunogenicity. Microorganisms 2023; 11(2) doi: 10.3390/microorganisms11020452
|
| 113 |
Sanskriti Varma, Stephen J Trudeau, Jianhua Li, Daniel E Freedberg. Proton pump Inhibitors and Risk of Enteric Infection in Inflammatory Bowel Disease: A Self-controlled Case Series. Inflammatory Bowel Diseases 2024; 30(1) doi: 10.1093/ibd/izad035
|
| 114 |
Brandy McKelvy, Jennifer Cortes, Anabelle Keene. Infection Prevention in the Intensive Care Setting. 2024; doi: 10.1007/978-3-031-67062-6_6
|
| 115 |
UZhe Ding, Lijin Ooi, Henry H. L. Wu, Rajkumar Chinnadurai. Clostridioides difficile Infection in Kidney Transplant Recipients. Pathogens 2024; 13(2) doi: 10.3390/pathogens13020140
|
| 116 |
Joachim Großmann, Sebastian Schulz-Stübner. Nosokomiale Pneumonien – Teil 1: Epidemiologie, Pathogenese, Diagnose und Therapie. Krankenhaushygiene up2date 2024; 19(01) doi: 10.1055/a-2061-6146
|
| 117 |
Qian Zeng, Chengfu Guan, Jiana Chen, Li Chen. Proton pump inhibitors and the risk of hospital acquired clostridioides difficile infection in critically ill patients. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1829764
|
| 118 |
Mikołaj Kamiński, Igor Łoniewski, Agata Misera, Wojciech Marlicz. Heartburn-Related Internet Searches and Trends of Interest across Six Western Countries: A Four-Year Retrospective Analysis Using Google Ads Keyword Planner. International Journal of Environmental Research and Public Health 2019; 16(23) doi: 10.3390/ijerph16234591
|
| 119 |
Deepika Dinesh, Xochitl C. Morgan, Hanseul Kim, Tammy M. Scott, Mahdi Garelnabi, Jong Soo Lee, Kelsey M. Mangano, Long H. Nguyen, Curtis Huttenhower, Katherine L. Tucker, Natalia Palacios. Gut Microbial Variations Associated With Proton Pump Inhibitor Use in the Boston Puerto Rican Health Study. Pharmacology Research & Perspectives 2026; 14(1) doi: 10.1002/prp2.70205
|
| 120 |
Min Hyuk Choi, Dokyun Kim, Seok Hoon Jeong, Hyuk Min Lee, Heejung Kim. Risk Factors of Severe Clostridioides difficile Infection; Sequential Organ Failure Assessment Score, Antibiotics, and Ribotypes. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.900681
|
| 121 |
Bojana Milenković, Vesna Šuljagić, Aneta Perić, Viktorija Dragojević-Simić, Olivera Tarabar, Milomir Milanović, Vesna Putić, Diana Tomić, Branislava Miljković, Sandra Vezmar Kovačević. Outcomes ofClostridioides difficileinfection in adult cancer and non-cancer patients hospitalised in a tertiary hospital: a prospective cohort study. European Journal of Hospital Pharmacy 2022; 29(e1) doi: 10.1136/ejhpharm-2020-002574
|
| 122 |
Joshua Bell, Jasmine Vatani, Micheal Raad, Lawal Labaran, Varun Puvanesarajah, Hamid Hassanzadeh. Clostridium difficile Infection Following Spine Surgery. Spine 2020; 45(22) doi: 10.1097/BRS.0000000000003627
|
| 123 |
Myung Jin Song, Seok Kim, Dachung Boo, Changhyun Park, Sooyoung Yoo, Ho Il Yoon, Young-Jae Cho. Comparison of proton pump inhibitors and histamine 2 receptor antagonists for stress ulcer prophylaxis in the intensive care unit. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-98069-7
|
| 124 |
Phung Anh Nguyen, Mohaimenul Islam, Cooper J Galvin, Chih-Cheng Chang, Soo Yeon An, Hsuan-Chia Yang, Chih-Wei Huang, Yu-Chuan (Jack) Li, Usman Iqbal. Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia. International Journal for Quality in Health Care 2020; 32(5) doi: 10.1093/intqhc/mzaa041
|
| 125 |
Umer Farooq, Zahid Ijaz Tarar, Faisal Kamal, Adnan Malik, Joseph Bresnahan, Ayokunle T. Abegunde. Is acid suppression associated with the increased length of stay in diabetic ketoacidosis patients? A nationwide analysis. Journal of Internal Medicine 2022; 292(1) doi: 10.1111/joim.13466
|
| 126 |
M. Dettori, N. Riccardi, D. Canetti, R.M. Antonello, A.F. Piana, A. Palmieri, P. Castiglia, A.A. Azara, M.D. Masia, A. Porcu, G.C. Ginesu, M.L. Cossu, M. Conti, P. Pirina, A. Fois, I. Maida, G. Madeddu, S. Babudieri, L. Saderi, G. Sotgiu. Infections in lung transplanted patients: A review. Pulmonology 2024; 30(3) doi: 10.1016/j.pulmoe.2022.04.010
|
| 127 |
Dorota Ksiądzyna, Adam Szeląg. The Proton Pump Inhibitors Use and COVID-19 from Prior to Vaccination Perspective: A Review. Digestive Diseases 2023; 41(3) doi: 10.1159/000527501
|
| 128 |
Peace Mpakaniye, Annelies Boven, Steven Callens, Lars Engstrand, Erika Vlieghe, Nele Brusselaers. Clostridioides difficile recurrence in individuals with and without cancer: a Swedish population-based cohort study. Infection 2024; 52(2) doi: 10.1007/s15010-024-02193-1
|
| 129 |
Alexandre Decros, Elise-Marie Minoc, Véronique Lelong-Boulouard, Basile Chrétien, Alexandre Meurant, Joachim Alexandre, Charles Dolladille, Cédric Villain. Association between exposure to proton pump inhibitors and delirium: a descriptive and disproportionality analysis of VigiBase. BMJ Open 2024; 14(10) doi: 10.1136/bmjopen-2023-081911
|
| 130 |
Jianyi Yin, Roy Elias, Lan Peng, Nicholas Levonyak, Annapoorani Asokan, Alana Christie, Nisa Kubiliun, James Brugarolas, Hans J. Hammers. Chronic Use of Proton Pump Inhibitors Is Associated With an Increased Risk of Immune Checkpoint Inhibitor Colitis in Renal Cell Carcinoma. Clinical Genitourinary Cancer 2022; 20(3) doi: 10.1016/j.clgc.2022.01.017
|
| 131 |
Neeraj Puro, Reena Joseph, Ferhat D. Zengul, Kenneth J. Cochran, Bernard C. Camins, Midge Ray. Predictors of Hospital-Acquired Clostridioides difficile Infection: A Systematic Review. Journal for Healthcare Quality 2020; 42(3) doi: 10.1097/JHQ.0000000000000236
|
| 132 |
Claire Kennedy, Joanne M. Bargman. Nolph and Gokal's Textbook of Peritoneal Dialysis. 2021; doi: 10.1007/978-3-319-90760-4_20-1
|
| 133 |
Ki-Byung Lee, Mina Lee, Jin Woong Suh, Kyung-Sook Yang, Youseung Chung, Jeong Yeon Kim, Sun Bean Kim, Jang Wook Sohn, Young Kyung Yoon. Clinical prediction rule for identifying older patients with toxigenic clostridioides difficile at the time of hospital admission. BMC Geriatrics 2023; 23(1) doi: 10.1186/s12877-023-03808-2
|
| 134 |
Ayu Watanabe, Junichi Kubo, Tomoka Sato, Shigo Takatori, Mayumi Iwahori, Hideaki Izumi, Hirokazu Tabata, Yuji Kohara, Kazuya Hiura. Influence of Development of Proton Pump Inhibitors andPotassium-competitive Acid Blockers on<i> Clostridioides Difficile</i> Infection. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 2022; 48(12) doi: 10.5649/jjphcs.48.570
|
| 135 |
Michael M. Sutton, Mathew J. Gregoski, Don C. Rockey. Overuse of Intravenous Proton-Pump Inhibitors in the Treatment of Low-Risk Upper Gastrointestinal Bleeding. Journal of Clinical Gastroenterology 2026; 60(3) doi: 10.1097/MCG.0000000000002211
|
| 136 |
Sarah Davies, Jimmy Zhang, Yongjun Yi, Eric R. Burge, Marc Desjardins, Peter C. Austin, Carl van Walraven. Derivation and internal validation of the multivariate toxigenic C. difficile diarrhea model and risk score for emergency room and hospitalized patients with diarrhea. Antimicrobial Stewardship & Healthcare Epidemiology 2024; 4(1) doi: 10.1017/ash.2024.58
|
| 137 |
Areeg Anwer Ali, Bhoomendra A. Bhongade, Fatima Mohamed Alkaabi, Hannah Wesley. The Effect of Proton Pump Inhibitors on Bone Mineral Density at Specific Anatomical Sites: A Systematic Review and Meta‐Analysis. BioMed Research International 2025; 2025(1) doi: 10.1155/bmri/1269905
|
| 138 |
Chia-Jung Kuo, Cheng-Yu Lin, Chun-Wei Chen, Chiu-Yi Hsu, Sen-Yung Hsieh, Cheng-Tang Chiu, Wey-Ran Lin. Risk of Enteric Infection in Patients with Gastric Acid Supressive Drugs: A Population-Based Case-Control Study. Journal of Personalized Medicine 2021; 11(11) doi: 10.3390/jpm11111063
|
| 139 |
Ji Hye Hwang, You-Kyung Choi. Herbal and Natural Product Interventions to Modulate Gut Microbiota in Acid Suppression-Associated Dysbiosis: a systematic review protocol. Journal of Pharmacopuncture 2026; 29(2) doi: 10.3831/KPI.2026.29.2.149
|
| 140 |
Sirasa Ruangritchankul, Nancye M Peel, Leila Shafiee Hanjani, Leonard C Gray. <p>The Changes in Medication Prescribing Among the Older People with Cognitive Impairment in the Acute Care Setting</p>. Clinical Interventions in Aging 2020; doi: 10.2147/CIA.S252432
|
| 141 |
Yun Hong, Ziqi Ye, Zhe Gao, Yuefeng Rao. Continuous improvement on the rationality of prophylactic injectable PPIs usage by a clinical pharmacist-led guidance team at a Chinese tertiary teaching hospital. Journal of International Medical Research 2020; 48(10) doi: 10.1177/0300060520954729
|
| 142 |
Thomas Frieling. Gastroösophageale Refluxkrankheit. Journal für Gastroenterologische und Hepatologische Erkrankungen 2019; 17(2) doi: 10.1007/s41971-019-0047-0
|
| 143 |
Khalid Al Sulaiman, Kholoud Al Aamer, Alaa Al Harthi, Saud Jaser, Abdulrahman Al Anazi, Sultan Al Subaie, Ramesh Vishwakarma. Comparison between esomeprazole 20 mg Vs 40 mg as stress ulcer prophylaxis (SUP) in critically ill patients: A retrospective cohort study. Pharmacology Research & Perspectives 2020; 8(4) doi: 10.1002/prp2.624
|
| 144 |
Shinako Miyano, Nobuaki Michihata, Ken-Ei Sada, Kazuaki Uda, Hiroki Matsui, Kiyohide Fushimi, Masaomi Nangaku, Hideo Yasunaga. Comparison of fracture risk between proton pump inhibitors and histamine-2 receptor antagonists in ANCA-associated vasculitis patients: a nested case–control study. Rheumatology 2021; 60(4) doi: 10.1093/rheumatology/keaa594
|
| 145 |
Takuma Murofushi, Tatsuya Yagi, Daiki Tsuji, Daisuke Furushima, Tomoyuki Fujikura, Kunihiko Itoh, Junichi Kawakami. Changes in estimated glomerular filtration rate in patients administered proton pump inhibitors: a single-center cohort study. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(7) doi: 10.1007/s00210-023-02890-y
|
| 146 |
Thomas X Lu, Matthew Dapas, Erika Lin, Trevor Peters, Atsushi Sakuraba. The influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis of randomised controlled studies. Gut 2021; 70(11) doi: 10.1136/gutjnl-2020-321609
|
| 147 |
Anna Peyton-Navarrete, Minh Hien Chau Nguyen, Alireza FakhriRavari. Prescribing Responsibly: Navigating the Tides of Deprescribing in Proton Pump Inhibitor Stewardship. Pharmacoepidemiology 2025; 4(3) doi: 10.3390/pharma4030015
|
| 148 |
Hyun Jin Song, Haesuk Park, Susan Park, Jin‐Won Kwon. The association between proton pump inhibitor use and the risk of tuberculosis: A case‐control study. Pharmacoepidemiology and Drug Safety 2019; 28(6) doi: 10.1002/pds.4773
|
| 149 |
Sam Harper, Muralikrishnan Kartha, Stuart Mealing, Lars Eftang, Robin Gaupset. Cost-effectiveness of RefluxStop compared to proton pump inhibitors and Nissen fundoplication for management of persistent gastroesophageal reflux disease in Norway. Cost Effectiveness and Resource Allocation 2025; 23(1) doi: 10.1186/s12962-025-00665-1
|
| 150 |
Erica Alves, Gurupadayya Bannimath, Prabitha Prabhakaran. Repositioning Proton Pump Inhibitors: Expanding Applications from Acid Suppression to Cancer Therapeutics. Clinical Cancer Drugs 2025; 11 doi: 10.2174/012212697X375313250623163944
|
| 151 |
Amit Kumar, Vandana Sahani, Shivanand Patil. A Comprehensive Review on Omeprazole: Pharmacological Effects and Its Adverse Effects. Journal for Research in Applied Sciences and Biotechnology 2025; 4(1) doi: 10.55544/jrasb.4.1.4
|
| 152 |
Alla Turshudzhyan, Sonia Samuel, Angela Tawfik, Micheal Tadros. Rebuilding trust in proton pump inhibitor therapy. World Journal of Gastroenterology 2022; 28(24): 2667-2679 doi: 10.3748/wjg.v28.i24.2667
|
| 153 |
Ljiljana Markovic-Denic, Vladimir Nikolic, Borislav Toskovic, Marija Brankovic, Bogdan Crnokrak, Viseslav Popadic, Aleksandra Radojevic, Dusan Radovanovic, Marija Zdravkovic. Incidence and Risk Factors for Clostridioides difficile Infections in Non-COVID and COVID-19 Patients: Experience from a Tertiary Care Hospital. Microorganisms 2023; 11(2) doi: 10.3390/microorganisms11020435
|
| 154 |
Katia Fettucciari, Alessandro Fruganti, Fabrizio Stracci, Andrea Spaterna, Pierfrancesco Marconi, Gabrio Bassotti. Clostridioides difficile Toxin B Induced Senescence: A New Pathologic Player for Colorectal Cancer?. International Journal of Molecular Sciences 2023; 24(9) doi: 10.3390/ijms24098155
|
| 155 |
S. Valette, A. Dory, B. Gourieux, J.-C. Weber. Évaluation de l’implantation d’un processus de dé-prescription des inhibiteurs de la pompe à protons (IPP) à l’aide d’un algorithme au sein d’un service de médecine interne. La Revue de Médecine Interne 2021; 42(8) doi: 10.1016/j.revmed.2020.11.014
|
| 156 |
|
| 157 |
Alyson M. Esteves, Brittney Bernardoni, Sophia Brown, Julie Farrar, Dina M. Filiberto, Brian J. Kopp, Ji Li, Melanie Madorsky, Megan J. Moore, Jenna S. Perrodin, Joanna K. Tallon, Tori R. Thompson, Matthew A. Roginski, Brian Murray. Major publications in the critical care pharmacotherapy literature: 2024. Journal of Critical Care 2025; 90 doi: 10.1016/j.jcrc.2025.155177
|
| 158 |
Bin Wu, Zhiyao He, Ting Xu. A Vanished Association Between Proton Pump Inhibitors and Clostridioides Difficile Infection After Minimizing Bias. Journal of Clinical Medicine 2025; 15(1) doi: 10.3390/jcm15010230
|
| 159 |
Thiruvinvamalai S. Dharmarajan. The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing. Journal of the American Medical Directors Association 2021; 22(1) doi: 10.1016/j.jamda.2020.09.046
|
| 160 |
Vlad A. Ionescu, Camelia C. Diaconu, Raluca S. Costache, Florentina Gheorghe, Andreea G. Andronesi, Gina Gheorghe. Predictive Factors for Death among Patients with Clostridium difficile Infection – A Single Center Experience Study. Romanian Journal of Military Medicine 2023; 126(4) doi: 10.55453/rjmm.2023.126.4.21
|
| 161 |
Natalia Di Tommaso, Antonio Gasbarrini, Francesca Romana Ponziani. Intestinal Barrier in Human Health and Disease. International Journal of Environmental Research and Public Health 2021; 18(23) doi: 10.3390/ijerph182312836
|
| 162 |
Ciro Celsa, Calogero Cammà. Editorial: proton pump inhibitor use in cirrhosis—a piece of the puzzle. Alimentary Pharmacology & Therapeutics 2021; 53(5) doi: 10.1111/apt.16250
|
| 163 |
N. Sopena, N. Freixas, F. Bella, J. Pérez, A. Hornero, E. Limon, F. Gudiol, M. Pujol. Impact of a training program on the surveillance of Clostridioides difficile infection. Epidemiology and Infection 2019; 147 doi: 10.1017/S0950268819001080
|
| 164 |
Sam Harper, Muralikrishnan Kartha, Stuart Mealing, Yves M. Borbély, Jörg Zehetner. Cost-effectiveness of the RefluxStop device for management of refractory gastroesophageal reflux disease in Switzerland. Journal of Medical Economics 2024; 27(1) doi: 10.1080/13696998.2024.2362564
|
| 165 |
Mo Li, Corina Behrenbruch, Alex Wong, Vinna An. Megacolon following ileostomy reversal due to Clostridium difficile. ANZ Journal of Surgery 2020; 90(9) doi: 10.1111/ans.16124
|
| 166 |
Loai Albarqouni, Ray Moynihan, Justin Clark, Anna Mae Scott, Anne Duggan, Chris Del Mar. Head of bed elevation to relieve gastroesophageal reflux symptoms: a systematic review. BMC Family Practice 2021; 22(1) doi: 10.1186/s12875-021-01369-0
|
| 167 |
Laura Räisänen, Heli Viljakainen, Kaija-Leena Kolho. Exposure to proton pump inhibitors is associated with the development of pediatric autoimmune diseases. Frontiers in Pediatrics 2023; 11 doi: 10.3389/fped.2023.1157547
|
| 168 |
Porrawee Pramotesiri, Krongtong Putthipokin, Sirasa Ruangritchankul. Drug Related Problems among Older Inpatients at a Tertiary Care Setting. Journal of Clinical Medicine 2024; 13(6) doi: 10.3390/jcm13061638
|
| 169 |
Hildenia B. R. Nogueira, Cecília L. Costa, Conceição S. Martins, Maria Luana G. S. Morais, Carlos Quesada-Gómez, Cibele B. M. Carvalho, Eliane de Oliveira Ferreira, Gerly Anne de Castro Brito. Infection with Clostridioides difficile ribotype 046 in a paediatric liver transplant patient.
Access Microbiology
2021; 3(10) doi: 10.1099/acmi.0.000268
|
| 170 |
Sam Harper, Lukasz Grodzicki, Stuart Mealing, Liz Gemmill, Paul J. Goldsmith, Ahmed R. Ahmed. Cost-effectiveness of a novel, non-active implantable device as a treatment for refractory gastro-esophageal reflux disease. Journal of Medical Economics 2023; 26(1) doi: 10.1080/13696998.2023.2201063
|
| 171 |
S. Knecht, T. Schmidt-Wilcke. Der zweite Blick: praktische diagnostische und therapeutische Checks in der rehabilitativen Neurologie. Der Nervenarzt 2020; 91(4) doi: 10.1007/s00115-020-00887-z
|
| 172 |
Mustafa Gandhi, Harleen Kaur Chela, Maxwell A. Barffour, Emily Bosak, Emily Reznicek, Kevin Luton, Matthew Bechtold, Yezaz A. Ghouri. Risk of Developing Clostridioides Difficile Infection with the Use of Proton Pump Inhibitors in Patients with Inflammatory Bowel Disease. Biologics 2025; 5(4) doi: 10.3390/biologics5040038
|
| 173 |
Tahmina Lata, Jodie Trautman, Philip Townend, Robert B Wilson. Current management of gastro-oesophageal reflux disease—treatment costs, safety profile, and effectiveness: a narrative review. Gastroenterology Report 2022; 11 doi: 10.1093/gastro/goad008
|
| 174 |
Charles Bussell, Jennifer Vincent, Karen Brust. Implementation of a multidisciplinary process to improve diagnostic stewardship of hospital-onset Clostridioides difficile infections. American Journal of Infection Control 2023; 51(12) doi: 10.1016/j.ajic.2023.06.005
|
| 175 |
Decio CHINZON, Gerson DOMINGUES, Nivia TOSETTO, Marcos PERROTTI. SAFETY OF LONG-TERM PROTON PUMP INHIBITORS: FACTS AND MYTHS. Arquivos de Gastroenterologia 2022; 59(2) doi: 10.1590/s0004-2803.202202000-40
|
| 176 |
Michael T. Eadon, Marc B. Rosenman, Pengyue Zhang, Cathy R. Fulton, John T. Callaghan, Ann M. Holmes, Kenneth D. Levy, Samir K. Gupta, David M. Haas, Raj Vuppalanchi, Eric A. Benson, Rolf P. Kreutz, Emma M. Tillman, Tyler Shugg, Rebecca C. Pierson, Brandon T. Gufford, Victoria M. Pratt, Yong Zang, Zeruesenay Desta, Paul R. Dexter, Todd C. Skaar. The INGENIOUS trial: Impact of pharmacogenetic testing on adverse events in a pragmatic clinical trial. The Pharmacogenomics Journal 2023; 23(6) doi: 10.1038/s41397-023-00315-w
|
| 177 |
Rhonda L. Stuart, Caroline Marshall, Glenys Harrington, Louisa Sasko, Mary-Louise McLaws, John Ferguson. ASID/ACIPC position statement – Infection control for patients with Clostridium difficile infection in healthcare facilities. Infection, Disease & Health 2019; 24(1) doi: 10.1016/j.idh.2018.10.001
|
| 178 |
Ana Paula V. Colombo, Adriana M. de Oliveira, Nobuhiko Kamada, Sho Kitamoto. Periodontitis and Inflammatory Bowel Diseases: Mechanistic Evidence. Journal of Periodontal Research 2026; doi: 10.1111/jre.70124
|
| 179 |
Geoffroy Desbuissons, Lucile Mercadal. Use of proton pump inhibitors in dialysis patients: a double-edged sword?. Journal of Nephrology 2021; 34(3) doi: 10.1007/s40620-020-00808-y
|
| 180 |
Chen Chen, Huizhu Liang, Meibo He, Ruqiao Duan, Yu Guan, Fangfang Wang, Liping Duan. Impact of short-term proton pump inhibitors vs. histamine-2 receptor antagonists on gut microbiota in patients with acute coronary syndrome: A multicenter randomized trial. Chinese Medical Journal 2025; 138(5) doi: 10.1097/CM9.0000000000003148
|
| 181 |
Caterina Nela Dumitru, Alina Oana Dumitru, Larisa Goroftei, Elena Niculet, Mariana Daniela Ignat, Liliana Baroiu, Aurel Nechita, Gabriela Balan. Pharmacomicrobiomics of Non-Antibiotic Drugs: Mechanisms and Clinical Consequences of Gut Microbiota Alterations. Pharmaceutics 2026; 18(6) doi: 10.3390/pharmaceutics18060651
|
| 182 |
Joris L. J. M. Müskens, Simone A. van Dulmen, Karin Hek, Gert P. Westert, Rudolf B. Kool. Low-value chronic prescription of acid reducing medication among Dutch general practitioners: impact of a patient education intervention. BMC Primary Care 2024; 25(1) doi: 10.1186/s12875-024-02351-2
|
| 183 |
Seung Young Kim, Kwang Jae Lee. Potential Risks Associated With Long-term Use of Proton Pump Inhibitors and the Maintenance Treatment Modality for Patients With Mild Gastroesophageal Reflux Disease. Journal of Neurogastroenterology and Motility 2024; 30(4) doi: 10.5056/jnm24059
|
| 184 |
Sam Harper, Muralikrishnan Kartha, Stuart Mealing, Davide Bona, Leonardo Vincenti, Adolfo Renzi, Luigi Bonavina. Cost-effectiveness of RefluxStop for gastroesophageal reflux disease: analysis from an Italian healthcare perspective. BMC Gastroenterology 2026; 26(1) doi: 10.1186/s12876-026-04747-z
|
| 185 |
Mohamed Saad, Hassan Mitwally. Lansoprazole-Induced Thrombocytopenia in a Critically Ill Patient: A Case Report. Journal of Pharmacy Practice 2020; 33(5) doi: 10.1177/0897190019838681
|
| 186 |
F. Prechter, A. Stallmach. Clostridium difficile auf der Intensivstation. Medizinische Klinik - Intensivmedizin und Notfallmedizin 2020; 115(2) doi: 10.1007/s00063-018-0459-1
|
| 187 |
Hafez Al-Momani, Iman Aolymat. Proton pump inhibitors and gastrointestinal symptoms among patients with COVID-19 infection. Annals of Medicine 2024; 56(1) doi: 10.1080/07853890.2024.2355581
|
| 188 |
Danial Haris Shaikh, Harish Patel, Rezwan Munshi, Haozhe Sun, Shehriyar Mehershahi, Ahmed Baiomi, Ahmed Alemam, Usman Pirzada, Iqra Nawaz, Kamrun Naher, Siddarth Hanumanthu, Suresh Nayudu. Patients with <i>Clostridium difficile</i> infection and prior appendectomy may be prone to worse outcomes. World Journal of Gastrointestinal Surgery 2021; 13(11): 1436-1447 doi: 10.4240/wjgs.v13.i11.1436
|
| 189 |
Giovanni Bruno, Piera Zaccari, Giulia Rocco, Giulia Scalese, Cristina Panetta, Barbara Porowska, Stefano Pontone, Carola Severi. Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified. World Journal of Gastroenterology 2019; 25(22): 2706-2719 doi: 10.3748/wjg.v25.i22.2706
|
| 190 |
Laura Maria Condur, Sergiu Ioachim Chirila, Luana Alexandrescu, Mihaela Adela Iancu, Andrea Elena Neculau, Filip Vasile Berariu, Lavinia Toma, Alina Doina Nicoara. Proton Pump Inhibitor Use in Older Adult Patients with Multiple Chronic Conditions: Clinical Risks and Best Practices. Journal of Clinical Medicine 2025; 14(15) doi: 10.3390/jcm14155318
|
| 191 |
Grazia Mazzeo, Luigi Aronne, Domenica Francesca Mariniello, Valentino Allocca, Maria Ilaria Palma, Francesco Saverio Cerqua, Carlo Iadevaia, Adriano Costigliola, Roberto Parrella, Andrea Bianco, Vanvitelli/Monaldi COVID Group. Which impact for proton pump inhibitors in SARS-COV-2 pneumonia. Monaldi Archives for Chest Disease 2021; doi: 10.4081/monaldi.2021.1803
|
| 192 |
Vijay Kher, Manav Wadhawan, Arun Wadhwa, Sadanand Shetty, Shrish Bhatnagar, Ram Y Prabhoo, Uday A Pai, Bhanu V Pillai, Chris D'souza, Manish Bhatnagar, Meena R Prabhoo, Venkatesh P Seshadri, Subhash C Manchanda. Multidisciplinary Consensus for Rationalizing the Use of Acid Suppressants in Children and Adults: CONFOR. Euroasian journal of hepato-gastroenterology 2024; 14(1) doi: 10.5005/jp-journals-10018-1430
|
| 193 |
Vesna Šuljagić, Bojana Milenković, Aneta Perić, Dragutin Jovanović, Vesna Begović-Kuprešanin, Srđan Starčević, Aleksandar Tomić, Sandra Vezmar Kovačević, Viktorija Dragojević-Simić. Healthcare associated Clostridioides difficile infection in adult surgical and medical patients hospitalized in tertiary hospital in Belgrade, Serbia: a seven years prospective cohort study. Libyan Journal of Medicine 2020; 15(1) doi: 10.1080/19932820.2019.1708639
|
| 194 |
Hye-Kyung Jung, Chung Hyun Tae, Kyung Ho Song, Seung Joo Kang, Jong Kyu Park, Eun Jeong Gong, Jeong Eun Shin, Hyun Chul Lim, Sang Kil Lee, Da Hyun Jung, Yoon Jin Choi, Seung In Seo, Joon Sung Kim, Jung Min Lee, Beom Jin Kim, Sun Hyung Kang, Chan Hyuk Park, Suck Chei Choi, Joong Goo Kwon, Kyung Sik Park, Moo In Park, Tae Hee Lee, Seung Young Kim, Young Sin Cho, Han Hong Lee, Kee Wook Jung, Do Hoon Kim, Hee Seok Moon, Hirota Miwa, Chien-Lin Chen, Sutep Gonlachanvit, Uday C Ghoshal, Justin C Y Wu, Kewin T H Siah, Xiaohua Hou, Tadayuki Oshima, Mi-Young Choi, Kwang Jae Lee. 2020 Seoul Consensus on the Diagnosis and Management of Gastroesophageal Reflux Disease. Journal of Neurogastroenterology and Motility 2021; 27(4) doi: 10.5056/jnm21077
|
| 195 |
Jiyoun Song, Bevin Cohen, Philip Zachariah, Jianfang Liu, Elaine L. Larson. Temporal change of risk factors in hospital-acquired Clostridioides difficile infection using time-trend analysis. Infection Control & Hospital Epidemiology 2020; 41(9) doi: 10.1017/ice.2020.206
|
| 196 |
Johanna C Meyer, Sean MacBride-Stewart , Joseph O Fadare, Ammar Abdulrahman Jairoun, Mainul Haque, Amos Massele, Santosh Kumar, Israel Abebrese Sefah, Phumzile P Skosana , Brian Godman. Key Considerations From a Health Authority Perspective When Proton Pump Inhibitors Are Used to Treat Gastroesophageal Reflux Disease (GERD) and Their Implications. Cureus 2022; doi: 10.7759/cureus.31918
|
| 197 |
Wenlei Liu, Jana Jakobs, Lothar Rink. Proton-Pump Inhibitors Suppress T Cell Response by Shifting Intracellular Zinc Distribution. International Journal of Molecular Sciences 2023; 24(2) doi: 10.3390/ijms24021191
|
| 198 |
R. Quera, P. Nuñez, C. von Muhlenbrock, R. Espinoza. Trasplante de microbiota fecal mediante colonoscopia en el tratamiento de la infección por Clostridioides difficile recurrente: Experiencia de un Centro Universitario. Revista de Gastroenterología de México 2024; 89(4) doi: 10.1016/j.rgmx.2024.03.005
|
| 199 |
Michael Mazzeffi, Samuel Galvagno, Clare Rock. Prevention of Healthcare-associated Infections in Intensive Care Unit Patients. Anesthesiology 2021; 135(6) doi: 10.1097/ALN.0000000000004017
|
| 200 |
Betul Danisman, Betul Cicek, Serkan Yildirim, Ismail Bolat, Deniz Kantar, Kirill S. Golokhvast, Dragana Nikitovic, Aristidis Tsatsakis, Ali Taghizadehghalehjoughi. Carnosic Acid Ameliorates Indomethacin-Induced Gastric Ulceration in Rats by Alleviating Oxidative Stress and Inflammation. Biomedicines 2023; 11(3) doi: 10.3390/biomedicines11030829
|
| 201 |
Abidemi S. Adenikinju, James E. Feng, Clementine A. Namba, Tyler A. Luthringer, Claudette M. Lajam. Gastrointestinal Complications Warranting Invasive Interventions Following Total Joint Arthroplasty. The Journal of Arthroplasty 2019; 34(11) doi: 10.1016/j.arth.2019.06.026
|
| 202 |
Seung In Seo, Seng Chan You, Chan Hyuk Park, Tae Joon Kim, You Sang Ko, Yerim Kim, Jong Jin Yoo, Jinseob Kim, Woon Geon Shin. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine‐2 receptor antagonists: A 15‐year hospital cohort study using a common data model. Journal of Gastroenterology and Hepatology 2020; 35(8) doi: 10.1111/jgh.14983
|
| 203 |
Matilda Finke, Annelies Boven, Erika Vlieghe, Lars Engstrand, Nicola Orsini, Nele Brusselaers. Proton pump inhibitors and the risk of Clostridioides difficile infection: A systematic review and dose-response meta-analysis. Journal of Infection 2025; 90(5) doi: 10.1016/j.jinf.2025.106488
|
| 204 |
Molly Jenee Buccola, Adhini Kuppuswamy Satheesh Babu, Henry A. Paz, Nizhoni Dawn Porter, Harini Srinivasan, Rachel Lyn Ricks, Keaton Rosquist, Jose Luis Torres, Ying Zhong, Thunder Jalili, Umesh D. Wankhade, Pon Velayutham Anandh Babu. Dietary Prebiotics Modulate Omeprazole‐Induced Alterations in the Gut Microbial Signature. Molecular Nutrition & Food Research 2025; 69(24) doi: 10.1002/mnfr.70307
|
| 205 |
Y N Yarushina, G B Kolotova, V A Rudnov, V A Bagin. Risk Factors for diarrhea associated with Clostridium difficile in patients at a clinical hospital. Terapevticheskii arkhiv 2019; 91(11) doi: 10.26442/00403660.2019.11.000337
|
| 206 |
Taryn B. Bainum, Kelly R. Reveles, Ronald G. Hall, Kelli Cornell, Carlos A. Alvarez. Controversies in the Prevention and Treatment of Clostridioides difficile Infection in Adults: A Narrative Review. Microorganisms 2023; 11(2) doi: 10.3390/microorganisms11020387
|
| 207 |
Lisa W.M. Leung, Mark M. Gallagher. Letter in reply to Gianni et al on “Prevention, diagnosis, and management of atrioesophageal fistula”. Pacing and Clinical Electrophysiology 2020; 43(11) doi: 10.1111/pace.14012
|
| 208 |
Lovepreet Singh, Kapil Kanwar, Ajeet Pal Singh. Proton pump inhibitors: An incisive review. Indian Journal of Pharmacy and Pharmacology 2021; 8(2) doi: 10.18231/j.ijpp.2021.019
|
| 209 |
Daniel De-la-Rosa-Martinez, Frida Rivera-Buendía, Patricia Cornejo-Juárez, Bertha García-Pineda, Carolina Nevárez-Luján, Diana Vilar-Compte. Risk factors and clinical outcomes for Clostridioides difficile infections in a case control study at a large cancer referral center in Mexico. American Journal of Infection Control 2022; 50(11) doi: 10.1016/j.ajic.2022.02.011
|
| 210 |
. 2021; doi: 10.70675/d7ade3b4z77f7z4442z9ef1zd716a2ba3edd
|
| 211 |
Mark Ayoub, Julton Tomanguillo, Carol Faris, Nadeem Anwar, Harleen Chela, Ebubekir Daglilar. Use of proton pump inhibitors improves outcomes in mild acute pancreatitis: A nationwide cohort study. Medicine 2024; 103(14) doi: 10.1097/MD.0000000000037694
|
| 212 |
Seung Won Lee, Eun Kyo Ha, Abdullah Özgür Yeniova, Sung Yong Moon, So Young Kim, Hyun Yong Koh, Jee Myung Yang, Su Jin Jeong, Sun Joon Moon, Joo Young Cho, In Kyung Yoo, Dong Keon Yon. Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching. Gut 2021; 70(1) doi: 10.1136/gutjnl-2020-322248
|
| 213 |
Biljana Damnjanović, Jovana Stanisavljević, Adi Hadžibegović, Ivan Rović, Đuro Šijan, Nemanja Jovanović, Sanja Ratković, Marija Milenković. Intensive care management of traumatic brain injury: How can mnemonics help?. Serbian Journal of Anesthesia and Intensive Therapy 2022; 44(5-6) doi: 10.5937/sjait2206105D
|
| 214 |
Ainhoa Fernández-Yunquera, Laura Carrión, Lucía Diéguez, Clara Villaseca, Andrés Conthe, Maricela Valerio, Mario Romero, Aranzazú Caballero, Fernando Díaz-Fontenla, Patricia Muñoz, Rafael Bañares, Diego Rincón. The development of Clostridioides difficile Infection is associated with the severity of liver disease and worsens survival in acutely decompensated cirrhosis. The American Journal of the Medical Sciences 2026; doi: 10.1016/j.amjms.2026.09.003
|
| 215 |
Joachim Großmann, Sebastian Schulz-Stübner. Nosokomiale Pneumonien – Teil 2: Präventionsmaßnahmen. Krankenhaushygiene up2date 2024; 19(02) doi: 10.1055/a-2268-9988
|
| 216 |
Omeprazole: A Proton Pump Inhibitor for the Management of Acid-Related Diseases. International Journal of Advanced Research in Science, Communication and Technology 2025; doi: 10.48175/IJARSCT-29679
|
| 217 |
Nele Brusselaers, Omid Sadr-Azodi, Lars Engstrand. Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden. Journal of Gastroenterology 2020; 55(4) doi: 10.1007/s00535-019-01652-z
|
| 218 |
Baoqiang Zhu, Long Chen, Xue Tao, Hong Zheng, Xia Li, Qingfang Wu, Enwu Long, Haixia Lin. Current research status and trends of potassium-competitive acid blockers in the treatment of acid-related diseases: a bibliometric analysis. Frontiers in Pharmacology 2025; 15 doi: 10.3389/fphar.2024.1477633
|
| 219 |
Ying Lian Xiao, Li Ya Zhou, Xiao Hua Hou, Yan Qing Li, Duo Wu Zou, Min Hu Chen. Chinese expert consensus on gastroesophageal reflux disease in 2020. Journal of Digestive Diseases 2021; 22(7) doi: 10.1111/1751-2980.13028
|
| 220 |
Issac E. Perry, Irene Sonu, Carmelo Scarpignato, Junichi Akiyama, Michio Hongo, Kenneth J. Vega. Potential proton pump inhibitor–related adverse effects. Annals of the New York Academy of Sciences 2020; 1481(1) doi: 10.1111/nyas.14428
|
| 221 |
Jason Laird. Magnetic sphincter augmentation device placement for treatment of gastroesophageal reflux. JAAPA 2020; 33(12) doi: 10.1097/01.JAA.0000721664.47053.0e
|
| 222 |
Yuquan Rao, Ruifeng Zeng, Xuebin Jiang, Jun Li, Xiaocou Wang. The Effect of Dexmedetomidine on Emergence Agitation or Delirium in Children After Anesthesia—A Systematic Review and Meta-Analysis of Clinical Studies. Frontiers in Pediatrics 2020; 8 doi: 10.3389/fped.2020.00329
|
| 223 |
Sophie Ribiere, Marie-Anne Guillaumot, Amélie Barré, Einas Abou Ali, Maximilien Barret, Stanislas Chaussade, Romain Coriat. Quel est le VRAI risque au long cours des inhibiteurs de la pompe à protons ?. La Presse Médicale 2019; 48(5) doi: 10.1016/j.lpm.2019.02.011
|
| 224 |
Jamie L. Wagner, Kayla R. Stover, Allison M. Bell, Katie E. Barber. Risk factors for development of initial Clostridioides difficile infection. Journal of Global Antimicrobial Resistance 2021; 25 doi: 10.1016/j.jgar.2021.02.012
|
| 225 |
Vanessa Lang, Katrin Gunka, Jan Rudolf Ortlepp, Ortrud Zimmermann, Uwe Groß. Risk Factors of Patients With Diarrhea for Having Clostridioides (Clostridium) difficile Infection. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.840846
|
| 226 |
Arthur Laquière, Felix Trottier-Tellier, Romina Urena-Campos, Pascal Lienne, Laurence Lecomte, Maria Katsogiannou, Guillaume Penaranda, Christian Boustière, Masanao Nakamura. Evaluation of Antireflux Mucosectomy for Severe Gastroesophageal Reflux Disease: Medium-Term Results of a Pilot Study. Gastroenterology Research and Practice 2022; 2022 doi: 10.1155/2022/1606944
|
| 227 |
Travis J. Kochan, Michelle S. Shoshiev, Jessica L. Hastie, Madeline J. Somers, Yael M. Plotnick, Daniela F. Gutierrez-Munoz, Elissa D. Foss, Alyxandria M. Schubert, Ashley D. Smith, Sally K. Zimmerman, Paul E. Carlson, Philip C. Hanna, Craig D. Ellermeier. Germinant Synergy Facilitates Clostridium difficile Spore Germination under Physiological Conditions. mSphere 2018; 3(5) doi: 10.1128/mSphere.00335-18
|
| 228 |
Muzaffer Uğraklı, Mehmet Zahid Koçak, Gülhan Dinç, Tuğrul Burak Genç, Melek Çağlayan, Selin Uğraklı, Engin Hendem, Muhammed Muhiddin Er, Dilek Çağlayan, Melek Karakurt Eryılmaz, Murat Araz, Çağlayan Geredeli, Ali Murat Tatlı, Orhan Önder Eren, Mehmet Artaç. The effect of concomitant proton pump inhibitor use on survival outcomes of Nivolumab-treated renal cell carcinoma patients: a multicenter study. Journal of Cancer Research and Clinical Oncology 2023; 149(11) doi: 10.1007/s00432-023-04844-6
|
| 229 |
Elma Mati, Lisa Mioux, Grégoire Ollagnier, Aziza Waissi, Nacera Benzerdjeb, Karima Messaoudi, Blandine De La Gastine, Fayçal Aouni, Sabiha Ahmine, Armelle Leperre, Nathalie Bleyzac. How could proton pump inhibitors de-prescription be managed in geriatric long-term care?. Therapies 2024; 79(6) doi: 10.1016/j.therap.2024.05.002
|
| 230 |
Y. L. Samoilov , V. V. Hnatiuk . ANTI-INFLAMMATORY AND ANTIOXIDANT PROPERTIES OF A NEW PHARMACEUTICAL COMPOSITION IN THE FORM OF TABLETS BASED ON DRY EXTRACT OF AIR LEAVES AND QUERCETIN. Medical Science of Ukraine (MSU) 2025; 21(2) doi: 10.32345/2664-4738.2.2025.09
|
| 231 |
Lanxiang Pu, Ting Jia, Shili Su, Liang Yang, Hong Yao, Yujie Su, Zhaowen Chen. Proton Pump Inhibitors Versus Histamine-2 Receptor Blockers for Stress Ulcer Prophylaxis on In-hospital Mortality Among Intensive Care Unit Patients Hospitalized for Major Adverse Cardiovascular and Cerebrovascular Events: Retrospective Cohort Study. Clinical Therapeutics 2024; 46(9) doi: 10.1016/j.clinthera.2024.06.020
|
| 232 |
Paul Feuerstadt, Jessica R. Allegretti, Erik R. Dubberke, Amy Guo, Adam Harvey, Min Yang, Viviana Garcia-Horton, Mirko Fillbrunn, Glenn Tillotson, Lindy L. Bancke, Kerry LaPlante, Kevin W. Garey, Sahil Khanna. Efficacy and Health-Related Quality of Life Impact of Fecal Microbiota, Live-jslm: A Post Hoc Analysis of PUNCH CD3 Patients at First Recurrence of Clostridioides difficile Infection. Infectious Diseases and Therapy 2024; 13(1) doi: 10.1007/s40121-023-00907-w
|
| 233 |
Mirela Nicoleta Voicu, Florica Popescu, Dan Nicolae Florescu, Ion Rogoveanu, Adina Turcu-Stiolica, Dan Ionut Gheonea, Vlad Florin Iovanescu, Sevastita Iordache, Sergiu Marian Cazacu, Bogdan Silviu Ungureanu. Clostridioides difficile Infection among Cirrhotic Patients with Variceal Bleeding. Antibiotics 2021; 10(6) doi: 10.3390/antibiotics10060731
|
| 234 |
Peia Lee, David Fike, Hui Yang, Ronald G. Hall, Steven Pass, Carlos A. Alvarez. Do the types and routes of proton pump inhibitor treatments affect clostridium difficile in ICU patients? A retrospective cohort study. Expert Review of Clinical Pharmacology 2021; 14(3) doi: 10.1080/17512433.2021.1890582
|
| 235 |
John P. Haran, Doyle V. Ward, Shakti K. Bhattarai, Ethan Loew, Protiva Dutta, Amanda Higgins, Beth A. McCormick, Vanni Bucci.
The high prevalence of
Clostridioides difficile
among nursing home elders associates with a dysbiotic microbiome
. Gut Microbes 2021; 13(1) doi: 10.1080/19490976.2021.1897209
|
| 236 |
Ronald D. Hills Jr., Benjamin A. Pontefract, Hillary R. Mishcon, Cody A. Black, Steven C. Sutton, Cory R. Theberge. Gut Microbiome: Profound Implications for Diet and Disease. Kompass Nutrition & Dietetics 2022; doi: 10.1159/000523712
|
| 237 |
Claire Kennedy, Joanne M. Bargman. Nolph and Gokal's Textbook of Peritoneal Dialysis. 2023; doi: 10.1007/978-3-030-62087-5_20
|
| 238 |
Lindsay M. Daniels, Wesley D. Kufel. Clinical review of Clostridium difficile infection: an update on treatment and prevention. Expert Opinion on Pharmacotherapy 2018; 19(16) doi: 10.1080/14656566.2018.1524872
|
| 239 |
Sam Harper, Lukasz Grodzicki, Stuart Mealing, Elizabeth Gemmill, Paul Goldsmith, Ahmed Ahmed. Budget Impact of RefluxStop™ as a Treatment for Patients with Refractory Gastro-oesophageal Reflux Disease in the United Kingdom. Journal of Health Economics and Outcomes Research 2024; 11(1) doi: 10.36469/001c.90924
|
| 240 |
Kevin T. Lynch, Christopher L. Cramer, William J. Kane, Traci Hedrick, Charles Friel, Sudheer Vemuru, Sook C. Hoang. A history of Clostridioides difficile infection portends infection recurrence and worse outcomes after stoma reversal. Surgery 2021; 170(1) doi: 10.1016/j.surg.2020.12.032
|
| 241 |
Stelian Stefanita Mogoanta, Stefan Paitici, Carmen Aurelia Mogoanta. Abdominal Surgery - A Brief Overview. 2021; doi: 10.5772/intechopen.97739
|
| 242 |
Nicole E. Omecene, Nicole Wilcox, Alexandra L. Cox, Pearl Ham, Ryan Ong, Andrew T. Barber, Kristin M. Zimmerman. A review of proton pump inhibitor use in cystic fibrosis and considerations for deprescribing. Pediatric Pulmonology 2024; 59(12) doi: 10.1002/ppul.27229
|
| 243 |
Ajay Kausheic Madhusuthanan, Maryam Afzal, Diana Turuzhbaeva, Hala Rahman, Mithum Senaratne, Mona Ajal Loueian, Rahul Goyal, Summayya Anwar. Impact of Gastric Acid Suppression on Clostridioides difficile Infection: A Systematic Review. Cureus 2026; doi: 10.7759/cureus.115565
|
| 244 |
Jacek Czepiel, Mirosław Dróżdż, Hanna Pituch, Ed J. Kuijper, William Perucki, Aleksandra Mielimonka, Sarah Goldman, Dorota Wultańska, Aleksander Garlicki, Grażyna Biesiada. Clostridium difficile infection: review. European Journal of Clinical Microbiology & Infectious Diseases 2019; 38(7) doi: 10.1007/s10096-019-03539-6
|